Léčba natriuretickými peptidy – konec mýtu?

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Natriuretic peptide treatment – the end of a myth?
Authors

ŠPINAROVÁ Lenka ŠPINAR Jindřich VÍTOVEC Jiří

Year of publication 2011
Type Article in Periodical
Magazine / Source Remedia
MU Faculty or unit

Faculty of Medicine

Citation
Field Cardiovascular diseases incl. cardiosurgery
Keywords natriuretic peptides; heart failure; treatment
Description An overview is presented of natriuretic peptides and their action in pathological conditions. The article describes the action and clinical use of nesiritide – a recombinant form of human B-type natriuretic peptide (hBNP) that is identical to endogenous B type natriuretic peptide (BNP). The therapeutic potential of omapatrilat, a novel endopeptidase inhibitor that prevents the degradation of natriuretic peptides, is also featured.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info